Microvascular Eye Receives CE Mark for Varicose Veins Treatment

Microvascular Eye Technology, a 2004-formed subsidiary of Micromedic Technologies, has received EU CE Mark certification for its treatment for varicose veins. The new tool, originally developed for eye application, is “SpiderCan”, a miniature syringe that can be used on small blood vessels.
Another Micromedic unit, Bio Med Technologies, also has good news: it’s marker for [...]

Foamix to Develop Medical Foam with Galderma

Foamix Ltd., a 2003-founded Israeli developer of dermatological foam medications has signed a deal with dermatology specialist Galderma to develop an innovative dermatological  foam jointly.  The foam will be used to treat atopic dermatitis, a disease which affects about 10% of infants and 3% of the total population in the United States. It’s main symptom [...]

Evogene and Compugen Break News

Evogene and Compugen have both made headlines today. The two companies are related - Evogen was spun off of Compugen six years ago as an independent startup. Evogen will receive NIS 7.2 million from venture capital fund AquAgro. The ag-biotech startup develops improved plants for the agricultural and biofuel industries through [...]

In the News: Fixya, Intercure, Mazor, Perytons

According to webware, tech-support startup Fixya will announce a partnership with Best Buy whereby “customers wanting to perform their own fixes (or trying to dig others out of trouble) can go to the Best Buy Web site and access http://geeksquad.fixya.com from the “Customer Service” tab. They can search by product, SKU, manufacturer, or product category, [...]

Israel Delivers: TechnoSpin, Gizmox, Endogun, Applicure

Today Israel’s innovators made all kinds of headlines from cleantech to medical devices to software security.
Let’s start with TechnoSpin. The four year old startup has raised $8 million from US VC 21 Ventures. They develop and produce rotors for small wind turbines which, it claims, are cheaper to produce and more easily assembled than competitor’s [...]

Cryotherapy Startup Arbel Medical in Second Round

Last month we reported on Core Dynamics, a company that develops technology to freeze human organs and increase their shelf life. Another Israeli startup, Arbel Medical, is developing office-friendly, next-generation , minimally invasive Cryo-therapy products for the treatment of breast tumors and other internal diseased tissue.
Founded in 2005, the company has previously raised $2.75 [...]

Epix Achieves Positive Results for Vasovist

Epix Pharmaceuticals is an Israeli biopharmaceutical established in 2000 that discovers and develops novel therapeutics using its proprietary in silico drug delivery platform. According to a press release, the company has “achieved positive results from the blinded, independent re-read of images of its novel blood pool MRA agent, Vasovist.” Previous re-read of images [...]

ES Vascular Gets CE Mark for Surgical Stapler

ES Vascular, which I wrote about a few weeks ago, has received a CE Mark of approval for its Open Aortic Stapler (OAS), enabling commercialization of the device in most European countries.  According to the press release, the device “enables one shot stapling of synthetic grafts to aorta in open repair of abdominal and thoracic aneurysmal and occlusive [...]

Medgenics to Begin Trials of Anaemia Treatment

Medgenics, a biopharmaceutical company founded eight years ago in Israel, is set to begin phase I/II trials of its EPODURE protein therapy by mid-2008, according to a press release. The test will provide data on safety and efficacy and is expected to be approved soon by the Israel Ministry of Health (MoH).
After raising nearly [...]

Protalix Gets $4M from Chief Scientist

Protalix BioTherapeutics announced yesterday that it received $4 million from Israel’s Office of the Chief Scientist to help it advance its clinical and pre-clinical drug development programs. The government grant program was setup to aid tech companies that have trouble seeking R&D financing from private investors.
Protalix, which was founded in 1994, intends to use [...]